FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Jubilant Cadista's Losartan Potassium Tablets, 25 mg, supporting the approval of this generic dosage form.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension
• Stroke

Drugs mentioned

• Losartan Potassium Tablets, 25 mg (LOSARTAN POTASSIUM)

Snippet

SUPPL AP for LOSARTAN POTASSIUM TABLETS, 25 MG (LOSARTAN POTASSIUM)